Embolotherapy Market in North America is Expected to Hold Around 40% Share by 2024

The global embolotherapy market is projected to reach $4.8 billion by 2024, progressing at a CAGR of 8.0% during the forecast period.

Globally, the adoption of embolic procedures for the management of various diseases is increasing, owing to the rising healthcare spending and increasing patient pool. Furthermore, most of the patients who are diagnosed at intermediate stage and advanced stage, do not respond to curative therapies, such as ablation, surgical resection, and liver transplantation. Thus, increasing pool of patients, at an advanced stage of various life-threatening diseases, which require embolotherapy intervention, is a key driver supporting the growth of the embolotherapy market.

Globally, the North American embolotherapy market is expected to hold around 40% share by 2024. This can be mainly attributed to the rising cases of chronic diseases and increasing geriatric population.

Europe, APAC, LATAM, and Middle East and Africa are the other regions, which hold considerable shares in the embolotherapy market, on account of rising prevalence of cancer, and peripheral vascular and neurological diseases in these regions.

Manufacturers in the embolotherapy market are involved in product launches to increase their shares. For instance, in 2018, Medtronic Plc launched OptiSphere embolization spheres in the U.S., as well as Concerto 3D detachable coil system in Ireland.

Browse full report at: https://www.psmarketresearch.com/market-analysis/embolotherapy-market

Stryker Corporation, Terumo Corporation, Sirtex Medical Limited, Merit Medical Systems, Meril Life Sciences Pvt. Ltd., Kaneka Corporation, Johnson and Johnson, Cook Medical Inc., Boston Scientific Corporation, BTG Plc, Balt Extrusion, and Acandis GmbH and Medtronic Plc are some of the major players operating in the global embolotherapy industry.

Read More

Global Clinical Laboratory Services Market Rising Growth and Future Analysis

The global clinical laboratory services market is growing significantly due to the advances in diagnostic techniques, increasing incidences of chronic diseases, and increasing geriatric population. Healthcare providers’ compliance for clinical diagnostic services is increasing due to the increasing demand for reducing hospitalization time and hospital readmission rates. This in turn propels the growth of the global clinical laboratory services market. Massive unexplored clinical laboratory services market in emerging economies is creating ample opportunities for the global clinical laboratory services market to grow at a considerable rate in the coming years. Several pharmaceutical companies investing huge capital for the development of advanced clinical laboratory devices is also supporting the demand for cost effective and efficient clinical laboratory services.

The global clinical laboratory services market is categorized as clinical laboratory service providers and clinical laboratory test types. Based on clinical laboratory service providers, the clinical laboratory services market is categorized as clinic-based laboratory service providers, stand-alone laboratory service providers, and hospital-based laboratory service providers. Based on clinical laboratory test types, the clinical laboratory services market is categorized as medical microbiology and cytology laboratory tests, clinical chemistry laboratory tests, human and tumor genetics tests, and other esoteric tests.

To Learn more about this report: http://bit.ly/2MGCoPb

Some of the factors driving the growth of the global clinical laboratory services market are advances in diagnostic techniques, increasing geriatric population, increasing healthcare providers’ compliance for diagnostic test and services, and increasing investment by big biopharmaceutical companies in the clinical laboratory services market. In addition, increasing prevalence of chronic diseases and increasing healthcare expenditure are supporting the growth of the global clinical laboratory services market. However, stringent regulatory requirements and lack of skilled professionals are some of the factors inhibiting the growth of the global clinical laboratory services market to some extent.

Some of the major players operating in the global clinical laboratory services market are ARUP Laboratories, Abbott Laboratories, Bio-Reference Laboratories, Charles River Laboratories, Bioscientia Healthcare, Genoptix Medical Laboratory, Healthscope Ltd, Laboratory Corporation Of America Holdings, Labco S.A., Quest Diagnostics Inc., Spectra Laboratories, Sonic Healthcare Limited, and Genoptix Medical Laboratory.

Read More

Medical Device Connectivity Market Predicts it to Witness Healthy Growth During the Forecast Period

The global medical device connectivity market is witnessing considerable growth due to increasing implementation of electronic health records and health information exchange systems, increasing regulations for improving healthcare quality, growing demand for home healthcare due to increasing geriatric population, improved diagnosis of patient, and increasing healthcare IT initiatives. Moreover, increasing prevalence of chronic diseases, increasing emphasis on care quality and patient safety, and increasing need to reduce healthcare costs through a connected healthcare environment are supporting the demand of medical device connectivity.

To Learn More About this Report: http://bit.ly/2MAUz99

The medical device connectivity aids in data analytics and growing adoption of telehealth solutions are also driving the growth of the market. Based on product type, the market for service segment is expected to grow at the faster rate compared to solution during the forecast period, due to increasing requirement for maximum consumption of connectivity solutions by the user, increasing regulatory requirements and healthcare reforms, increasing implementation of healthcare information exchange system, and increasing need for effective implementation.

Inquiry Before Purchase at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=medical-device-connectivity-market

The increasing demand for remote patient monitoring and telehealth, and increasing alliance in the healthcare industry are expected to create opportunities for the players in the market. In addition, immense unexplored market in developing economies are creating abundant opportunities for the medical device connectivity market to grow at a significant rate in the coming years. However, high cost of implementation for medical device connectivity platform in small healthcare organizations, lack of integration between various hospital information systems and medical devices, lack of standard interface, interoperability issues, security concerns, cost barrier for small healthcare units, and risk of data breaches are the key factors hampering the growth of the global market.

The key players operating in the global medical device connectivity market are GE Healthcare, Cerner Corporation, Cisco Systems Inc., Qualcomm Inc., Koninklijke Philips N.V., Medtronic Plc., Infosys Limited, and Digi International Inc.

Read More

Companion Diagnostics Market Rising Growth and Future Analysis

Companion diagnostics offers a set of tools that facilitates biological and clinical information to the pharmaceutical companies that they have to overcome. Companion diagnostics help physicians to improve the treatment decisions for the patients depending on their response to current treatments. Companion diagnostics approach to medication is transforming the healthcare industry by eliminating unfavorable reactions, improving treatment outcomes, and reducing the cost and time difficulties associated with conventional methods of medication. Companion diagnostic is basically a bio-analytical method designed to evaluate whether the patient will respond favorably to the specific medical treatment or not. The market is fully dependent on discovery of biomarkers, and research and development of new drugs. With the surge in research and development of targeted rehabilitations and innovation of new biomarkers for a range of conditions, the global companion diagnostics market is growing at healthy rate.

Increasing scope for companion diagnostics and emerging technologies, such as next-generation sequencing (NGS), are some of the major opportunities for the global companion diagnostics market. Some of the major factors driving the growth of global companion diagnostics market are growing adoption of companion diagnostics by pharmaceutical companies and reference laboratories, regulatory bodies encouraging implementation of companion diagnostics, increasing demand and developmental of personalized medicine and rising demand for targeted cancer treatment.

To Learn more About this Report: http://bit.ly/2MAOqcP

Reimbursement scenario, effect of influence of advocacy groups and clinical societies, and extended developmental and approval phases are some of the factors that are restraining the growth of global companion diagnostics market. One of the major challenges for the companion diagnostics market is co-ordination in the development of drugs and diagnostics together.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=companion-diagnostics-market

North America had the largest companion diagnostics market because of the increasing incidence of cancer and increased healthcare awareness. Whereas, Asia-Pacific is the fastest growing market of companion diagnostics owing to the strengthening healthcare services and increasing medical tourism in developing countries such as India and China.

Read More

Adhesion Barrier Market is Expected to Generate Revenue of $833.1 Million by 2023

Growth in geriatric population, coupled with the rising incidence of chronic diseases, is resulting in an increased number of surgeries across the world. Along with advancements in healthcare technology, these have become the major growth factors for the global adhesion barrier market. Valued at $541.3 million in 2017, the domain is expected to generate revenue of $833.1 million by 2023, progressing at a CAGR of 7.5% during forecast period.

Adhesion barrier is a physical barrier applied between the layers of tissue during surgery, so that operated-upon tissues do not overlap with other tissues and organs while healing. Once the surgical site heals, the barrier itself is dissolved and absorbed by the body. The adhesion barrier market has been segmented by product, formulation, application, and geography. Adhesion barriers are available in two product types: synthetic and natural. Of the two, synthetic adhesion barriers were preferable during the historical period 2013–2017, owing to their higher flexibility and bioabsorbility. In 2017, these made a revenue contribution of 67.2% to the market.

To Learn More About this Report: http://bit.ly/2oczdqr

According to a report published by the World Health Organization (WHO) in 2016, approximately 266–360 million surgeries were performed in 2012 globally. Due to the increasing incidents of chronic diseases, such as arthritis and cardiovascular diseases, which require surgical intervention as a therapeutic procedure, the demand for adhesion barriers has increased. This is expected to drive the growth of adhesion barrier market in the forecast period.

GLOBAL ADHESION BARRIER MARKET SEGMENTATION

By Type of Product

• Synthetic Adhesion Barrier
• Regenerated Cellulose
• Hyaluronic Acid
• Polyethylene Glycol
• Others
• Natural Adhesion Barrier
• Fibrin Based
• Collagen & Protein Based

By Product Form

• Film Formulation
• Gel Formulation
• Liquid Formulation

By Application

• Gynecological Surgeries
• Cardiovascular Surgeries
• Neurological Surgeries
• Orthopedic Surgeries
• General/Abdominal Surgeries
• Urological Surgeries
• Others

By Geography

• North America - U.S. and Rest of North America
• Europe - U.K., Germany, France and Rest of Europe
• Asia-Pacific - China, Japan, India and Rest of Asia-Pacific
• Latin America – Brazil, Mexico and Others
• Middle East and Africa

Read More